Unstable angina pathophysiology centers on a dynamic imbalance between myocardial oxygen demand and supply, primarily triggered by the sudden rupture of an atherosclerotic plaque. This event initiates a cascade of thrombosis and inflammation, leading to acute coronary artery narrowing without the irreversible myocardial necrosis seen in a myocardial infarction. The clinical hallmark is ischemia at rest or with minimal exertion, signaling a critical phase of coronary artery disease that demands immediate intervention.
Plaque Rupture and Thrombosis: The Core Mechanism
The fundamental event in unstable angina pathophysiology is the erosion or rupture of a vulnerable atherosclerotic plaque. These plaques, often rich in a lipid core and a thin fibrous cap, become inflamed and mechanically unstable. When the cap ruptures, the highly thrombogenic lipid core and tissue factor are exposed to the bloodstream, instantly activating the coagulation cascade. This triggers the formation of a platelet-rich thrombus that rapidly adheres to the site of injury, causing acute and often unpredictable occlusion of the coronary lumen.
From Stable to Unstable: The Vulnerable Plaque
Understanding unstable angina requires appreciating the transition from a stable atherosclerotic lesion. Stable plaques typically have a thick fibrous cap and a small lipid core, causing chronic, predictable stenosis. In contrast, the vulnerable plaque responsible for unstable angina is characterized by a large lipid core, a thin cap, and a prominent inflammatory infiltrate. This structural instability makes it prone to sudden rupture, transforming a previously quiescent lesion into the primary driver of acute ischemic symptoms.
The Inflammatory Cascade and Its Amplifying Role
Inflammation is not merely a bystander but a central protagonist in unstable angina pathophysiology. Cytokines like interleukin-6 and tumor necrosis factor-alpha, released by macrophages within the plaque, degrade the fibrous cap and weaken its integrity. Furthermore, systemic inflammation markers, such as C-reactive protein, correlate with increased risk. This inflammatory milieu also promotes endothelial dysfunction, reducing the availability of nitric oxide, a critical vasodilator, thereby exacerbating coronary spasm and microvascular resistance.
Coronary Vasospasm and Microvascular Dysfunction
Beyond epicardial thrombosis, unstable angina pathophysiology involves dynamic coronary vasospasm and microvascular dysfunction. The exposed plaque and thrombus release vasoactive substances like serotonin and thromboxane A2, which can cause the coronary artery to constrict paradoxically. Additionally, the inflammatory process can impair the microvasculature's ability to dilate, creating a state of profound, localized ischemia even in the absence of complete large vessel occlusion. This contributes significantly to the clinical variability of symptoms.
Clinical Manifestations Reflecting Pathophysiological Stress
The clinical presentation of unstable angina is a direct reflection of its underlying pathophysiology. The pain occurs at rest or with minimal exertion because the plaque rupture and thrombus formation can occur spontaneously, independent of physical stress. The severity and unpredictability of symptoms, such as chest pain at night or during sleep, are linked to the intermittent nature of thrombus formation and the heart's changing oxygen demands during autonomic fluctuations.
Diagnostic and Prognostic Implications of Pathophysiology
Diagnostic strategies for unstable angina are designed to detect the biomarkers of myocardial necrosis and ischemia resulting from this pathophysiological process. While cardiac troponin levels remain normal (distinguishing it from myocardial infarction), they confirm ongoing myocardial stress. Electrocardiographic changes and imaging techniques like stress testing or coronary angiography visualize the location and severity of the obstructive thrombus, guiding therapeutic decisions based on the severity of the anatomical and physiological disturbance.
